Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other AI news and ...

Subway® continues to celebrate another year of keeping it fresh with a first-of-its-kind, footlong-sized collaboration to ...

Transcend is partnering with Nomura, one of the world's leading financial services firms, to implement Cash and Collateral Management modules that are built on Transcend's pioneering technology. By ...

Freeport-McMoRan and Gilead Sciences received the next highest rankings ... only a few clicks away and dedicated landing pages for the annual meeting. Runner up: Cognizant Technology. Best Code of ...

(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware ...

Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of global commercial, he announced on LinkedIn this week. “CAR T-cell therapy has changed ...

Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs By Blake Brittain (Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over ...